anti-RBD IgG

Biomarker

1 paper1 finding

  • Humans1

Interventions

1

BNT162B2

upin humans1

1 study
  1. BNT162B2 increases anti-RBD IgG in humans.

    “Anti-RBD IgG titers increased in nearly all participants, with no measurable impact of age, sex, infection history, or CMV status”

    Human trialn = 41

    Immunosenescence and cytomegalovirus-associated immune signatures on severe acute respiratory syndrome coronavirus 2 booster responses

    The journals of gerontology. Series A, Biological sciences and medical sciences7 Apr 2026

More on BNT162B2

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months